Philippines - English - FDA (Food And Drug Administration)

hipra philippines, inc.; distributor: hipra philippines, inc. - inactivated porcine parvovirus , erysipelothrix rhusiopathiae , leptospira interrogans serovar icterohaemorrhagiae , leptospira interrogans serovar canicola , leptospira interrogans serovar pomona , leptospira interrogans serovar hardjo , leptospira interrogans serovar grippotyphosa , leptospira interrogans serovar bratislava vaccine (vet.) - suspension for injection (im) - each 2ml (dose) contains porcine parvovirus (nadl-2 strain) >1.15* eryspelothrix rhusiopathiae (r32e11 strain)>3.34** leptospira interrogans serovar icterohaemorrhagiae->108mo leptospira interrogans serovar canicola-->108mo leptospira interrogans serovar pomona-->108mo leptospira interrogans serovar hardjo-->108mo leptospira interrogans serovar grippotyphosa-->108mo leptospira interrogans serovar bratislava-->108mo *rp, relative potency (elisa) **ies. (inhibition elisa 50%) mo - microorganismus

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - azithromycin as dihydrate - powder for solution for infusion - azithromycin as dihydrate 500 mg/vial - azithromycin - azithromycin - treatment of infections caused by susceptible strains of the designated microorganisms in the following conditions: community-acquired pneumonia and pelvic inflammatory disease.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - azithromycin as dihydrate - powder for solution for infusion - azithromycin as dihydrate 500 mg/vial - azithromycin - azithromycin - treatment of infections caused by susceptible strains of the designated microorganisms in the following conditions: community-acquired pneumonia and pelvic inflammatory disease.

Israel - English - Ministry of Health

novartis israel ltd - ciprofloxacin as hydrochloride - solution - ciprofloxacin as hydrochloride 3 mg/ml - ciprofloxacin - ciprofloxacin - corneal ulcers and conjunctivitis caused by susceptible gram positive and gram negative microorganisms for adults and pediatric patients above the age of 1 year. for localized or diffuse otitis externa accompanied by a strong inflammatory reaction and of which the strains are susceptible to ciprofloxacin, and for the acute flare-up of a chronic otitis media. in this case, a mucopurulent secretion comes through the perforated eardrum. pseudomonas aeruginosa is one of the organisms most likely to be found in this case. also in other infections of the ear in which pseudomonas aeruginosa and/or other susceptible strains may be demonstrated or suspected (for example with suppurating tympanic tubes), ciloxan can be used under the strict supervision of an ear specialist. it must be understood that this is not a routine treatment and that improper use must be avoided.

Singapore - English - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - ciprofloxacin hydrochloride - tablet, film coated - 500 mg - ciprofloxacin hydrochloride 582.0 mg

Singapore - English - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - ciprofloxacin lactate eqv ciprofloxacin - injection - 200 mg/100 ml - ciprofloxacin lactate eqv ciprofloxacin 200 mg/100 ml

Singapore - English - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - ciprofloxacin hydrochloride - tablet, film coated - 250 mg - ciprofloxacin hydrochloride 291.0mg

Australia - English - Department of Health (Therapeutic Goods Administration)

f&m family trust t/a cell biosciences - ct922 - microbiological culture media ivds - lyophilized, reference stock culture preparations containing microorganism / s. these microorganism preparations are intended to be used for quality control of culture media.

Israel - English - Ministry of Health

mbi pharma ltd., israel - azithromycin as dihydrate - powder for solution for infusion - azithromycin as dihydrate 500 mg - azithromycin - treatment of infections caused by susceptible strains of the designated microorganisms in the following conditions: community-acquired pneumonia and pelvic inflammatory disease.

Philippines - English - FDA (Food And Drug Administration)

hipra philippines, inc.; distributor: hipra philippines, inc. - inactivated porcine parvovirus , erysipelothrix rhusiopathiae , leptospira interrogans serovar icterohaemorrhagiae , leptospira interrogans serovar canicola , leptospira interrogans serovar pomona , leptospira interrogans serovar hardjo , leptospira interrogans serovar grippotyphosa , leptospira interrogans serovar bratislava vaccine (vet.) - suspension for injection (im) - each 2ml (dose) contains: porcine parvovirus (nadl-2 strain) eryspelothrix rhusiopathiae (r32e11 strain) leptospira interrogans serovar icterohaemorrhagiae leptospira interrogans serovar canicola leptospira interrogans serovar pomona leptospira interrogans serovar hardjo leptospira interrogans serovar grippotyphosa leptospira interrogans serovar bratislava *rp, relative potency (elisa) **iesu (inhibition elisa 50%) mo - microorganisms >1.15* >3.34** 208 mo 10 mo 10 mo 30 mo 10 mo 10 mo